Ganglioneuroblastoma
Clinical trials for Ganglioneuroblastoma explained in plain language.
Never miss a new study
Get alerted when new Ganglioneuroblastoma trials appear
Sign up with your email to follow new studies for Ganglioneuroblastoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with aggressive cancer: tailored therapy trial launches
Disease control Recruiting nowThis study is for children newly diagnosed with high-risk neuroblastoma, a rare and aggressive nerve cancer. It uses genetic testing to choose personalized chemotherapy, then tests whether adding the drug DFMO to standard immunotherapy helps prevent relapse. About 500 children wi…
Matched conditions: GANGLIONEUROBLASTOMA
Phase 2 • Sponsor: Giselle Sholler • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Promising new combo therapy aims to improve survival in kids with aggressive nerve cancer
Disease control Recruiting nowThis study tests whether adding a radioactive drug (131I-MIBG) or a targeted pill (lorlatinib) to standard intensive therapy helps children and young adults with newly diagnosed high-risk neuroblastoma live longer without the cancer returning. About 750 participants aged 1 to 30 …
Matched conditions: GANGLIONEUROBLASTOMA
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Engineered immune cells take aim at childhood cancer
Disease control Recruiting nowThis study tests a new treatment for children and young adults with neuroblastoma that has returned or not responded to standard care. The treatment uses specially engineered immune cells from donated cord blood that are designed to recognize and attack two different markers on t…
Matched conditions: GANGLIONEUROBLASTOMA
Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for tough tumors: Half-Matched bone marrow transplant trial
Disease control Recruiting nowThis study is testing a bone marrow transplant from a half-matched family donor for people with high-risk solid tumors that have come back or not responded to treatment. Participants receive mild chemotherapy and radiation before the transplant, along with drugs to prevent reject…
Matched conditions: GANGLIONEUROBLASTOMA
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for kids with aggressive nerve cancer: immune-boosting combo trial opens
Disease control Recruiting nowThis phase 3 trial tests a powerful mix of chemotherapy, immunotherapy, and the child's own natural killer (NK) cells for children aged 1.5 to 18 with high-risk neuroblastoma that didn't respond or came back. The goal is to shrink tumors and improve survival by helping the immune…
Matched conditions: GANGLIONEUROBLASTOMA
Phase 3 • Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC